Easy Trade Mark not so for Stelios or The Daily Telegraph!
The Daily Telegraph has managed to mangle its piece on the use of ‘easy’ in trade marks today by calling it a ‘copyright’ battle! The general rule is do not
Patents and Trade Secrets Go Hand in Hand for ‘Pharma’ Companies
Most of us are familiar with biologic medicines from taking flu vaccines and covid treatments. Biologics present a wave of breakthrough medicines for cancer, diabetes, arthritis et
We spend a million a year on patents and nothing on trade secrets!
This approach is good for the patent attorneys but how good is it for your business? What this statement says is that ‘we do not have any proprietary information worth protecting
6.5m people’s data stolen in the Coop hack but that’s not the story!
Business wants you to focus on the smokescreen 1 in 10 of the UK population had data stolen from the Coop! The hackers no doubt sold the credit card and DoB info on the dark web Wh
Investors Treat IP Protection as a Core Competency, Invest In Firms Showing They Are Able To Secure Their Secrets
We are seeing this more and more: IP gets stolen and the share price falls. 12 % fall in the case of ASML The ASML internal spy was able to steal secrets about the EUs most strateg
‘The Error Exists between the Keyboard and Screen’!
Blame it on the new boy Sensitive UK government data emailed on excel spreadsheet, breached and leaked on Facebook. The UK government says: ‘this was a clear breach of data prote
Dope Wimbledon champions, how about cycling?
Cycling 108 miles at 30mph average speed! Both men and women’s Wimbledon singles champions in 2025 have served doping bans! This doping fact is barely whispered, why? Yet if
Intangibles an increasingly important investment as a % of GDP
Intangible investment (as a share of GDP) surpassed tangible investment (as a share of GDP) for the first time in 2009, and the gap has been widening ever since. World Intangible I
Iron Man exhausted but happy!
“John Pryor you are iRon-man” golden words from the compere at IRONMAN Switzerland, July 2014. It wasn’t fast and it certainly wasn’t pretty, but we did it, two yea
How do you know when a patent has expired? Sales fall $12bn in two years.
When pharma patents expire sales drop off a cliff. From $21bn to $14bn to $9bn in two years for AbbVie’s Humira. The reason: generics jump in and replace branded product. The pha
